No Data
No Data
Trump Renews Push for Most-Favored-Nation Drug Pricing. What It All Means
Trump Says Prescription Drug Prices Set To Drop By 30% To 80% 'Almost Immediately' Thanks To 'Most Favored Nation' Plan, Mark Cuban Urges President To 'Force Transparency'
Kamada (KMDA) Q1 Earnings Preview: What You Should Know Beyond the Headline Estimates
Sidoti Initiates Kamada(KMDA.US) With Hold Rating, Announces Target Price $13
Earnings Preview: Kamada to Report Financial Results Pre-market on May 14
Kamada | 6-K: Report of foreign private issuer (related to financial reporting)